Back to search

Article

ARB/ACEI use and severe COVID-19: a nationwide case-control study

2020-06-13

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> Angiotensin receptor blockers (ARBs) and angiotensin converting enzyme inhibitors (ACEIs) have anti-inflammatory effects. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses the membrane protein angiotensin-converting enzyme 2 (ACE2), which is increased by ARB/ACEI treatment, as a cell entry receptor. Therefore, the use of ARBs/ACEIs for COVID-19 remains controver...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
843f8b77-6937-5f8d-97da-5e228b021e94
DOI
10.1101/2020.06.12.20129916
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ARB/ACEI use and severe COVID-19: a nationwide case-control studyDOI 10.1101/2020.06.12.20129916
Select a neighboring publication to make it the new centre.